A novel pathway for regulation of glucose‐dependent insulinotropic polypeptide receptor expression in β‐cells

Glucose‐dependent insulinotropic polypeptide (GIP) is secreted postprandially and acts in concert with glucose to stimulate insulin secretion from the pancreas. Here, we describe a novel pathway for the regulation of GIP receptor (GIPR) expression within clonal β‐cell lines, pancreatic islets, and in vivo. High (25 mM) glucose was able to significantly reduce GIPR mRNA levels in INS(832/13) cells after only 6 h. In contrast, palmitic acid (2 mM) and WY 14643 (100 μM) stimulated approximate doublings of GIPR expression in INS(832/13) cells under low (5.5 mM), but not high (25 mM), glucose conditons, suggesting that fat can regulate GIPR expression via PPARα in a glucose‐dependent manner. Both MK‐886, an antagonist of PPARα, and a dominant negative form of PPARα transfected into INS(832/13) cells caused a significant reduction in GIPR expression in low, but not high, glucose conditions. Finally, in hyperglycemic clamped rats, there was a 70% reduction in GIPR expression in the islets and a 71% reduction in GIP‐stimulated insulin secretion from the perfused pancreas. Thus, evidence is presented that the GIPR is controlled at normoglycemia by the fatty acid load on the islet; however, when exposed to hyperglycemic conditions, the GIPR is down‐regulated, which may contribute to the decreased responsiveness to GIP that is observed in type 2 diabetes.

[1]  C. Heinlein,et al.  Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor γ through Inhibition of Pax6 Transcriptional Activity* , 2002, The Journal of Biological Chemistry.

[2]  D. Hörsch,et al.  Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. , 2001, Molecular endocrinology.

[3]  R. Pederson,et al.  A New Pathway for Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Signaling , 2001, The Journal of Biological Chemistry.

[4]  S. Biswal,et al.  Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886 , 2001 .

[5]  R. Pederson,et al.  Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. , 2001, Diabetes.

[6]  S. Bonner-Weir,et al.  beta-cell adaptation to hyperglycemia. , 2001, Diabetes.

[7]  M. Prentki,et al.  Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell* , 2000, The Journal of Biological Chemistry.

[8]  R. Pederson,et al.  Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide. , 2000, The Journal of endocrinology.

[9]  M. Prentki,et al.  Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. , 2000, Diabetes.

[10]  M. Prentki,et al.  Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell. , 2000, The Journal of biological chemistry.

[11]  J. Miyazaki,et al.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[13]  S. Seino,et al.  PKA‐mediated phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation , 1999, The EMBO journal.

[14]  B Staels,et al.  A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. , 1999, Molecular endocrinology.

[15]  R. Unger,et al.  Novel Form of Lipolysis Induced by Leptin* , 1999, The Journal of Biological Chemistry.

[16]  M. Wolfe,et al.  Effect of GIP and GLP-1 antagonists on insulin release in the rat. , 1999, American journal of physiology. Endocrinology and metabolism.

[17]  L. Orci,et al.  Regulation of fatty acid homeostasis in cells: novel role of leptin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[19]  S. Walker,et al.  Quantitative RT-PCR : Pitfalls and Potential , 1999 .

[20]  R. Pederson,et al.  Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. , 1999, Endocrinology.

[21]  B. Göke,et al.  Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. , 1998, The Journal of clinical investigation.

[22]  C. Newgard,et al.  Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Holst,et al.  The pathogenesis of NIDDM involves a defective expression of the GIP receptor , 1997, Diabetologia.

[24]  D. D’Alessio,et al.  Peptide Hormone Regulation of Islet Cells , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[25]  M. Prentki,et al.  Signal transduction mechanisms in nutrient-induced insulin secretion , 1997, Diabetologia.

[26]  J. Gromada,et al.  Protein Kinase A-Dependent Stimulation of Exocytosis in Mouse Pancreatic β-Cells by Glucose-Dependent Insulinotropic Polypeptide , 1997, Diabetes.

[27]  M. Prentki,et al.  Fatty Acids Rapidly Induce the Carnitine Palmitoyltransferase I Gene in the Pancreatic β-Cell Line INS-1* , 1997, The Journal of Biological Chemistry.

[28]  T. Usdin,et al.  Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. , 1996, The Journal of clinical investigation.

[29]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[30]  E. Ah-Sing,et al.  Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by Electrofusion , 1996, Diabetes.

[31]  Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP): Effect of a GIP-specific receptor antagonist , 1996, Regulatory Peptides.

[32]  J. Brown,et al.  GIP receptors and signal-transduction mechanisms. , 1996, Acta physiologica Scandinavica.

[33]  J. Brown,et al.  Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. , 1995, Endocrinology.

[34]  K. Griffin,et al.  A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators. , 1995, Molecular pharmacology.

[35]  R. Pederson,et al.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. , 1995, Endocrinology.

[36]  J. Holst,et al.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.

[37]  V. Marks,et al.  Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. , 1991, The Journal of endocrinology.

[38]  C. Strader,et al.  Insulin receptor desensitization correlates with attenuation of tyrosine kinase activity, but not of receptor endocytosis. , 1987, The Biochemical journal.

[39]  B. Beck,et al.  Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat , 1983, Regulatory Peptides.

[40]  J. Brown,et al.  Effect of jejunoileal bypass in the rat on the enteroinsular axis , 1982, Regulatory Peptides.

[41]  J. Brown,et al.  The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. , 1976, Endocrinology.

[42]  J. Brown,et al.  Gastric Inhibitory Polypeptide: Its Physiologic Release and Insulinotropic Action in the Dog , 1975, Diabetes.

[43]  J. Brown,et al.  The insulinotropic action of gastric inhibitory polypeptide. , 1975, Canadian journal of physiology and pharmacology.